Ghayda’ AlDabet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ghayda’ AlDabet has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Nidal A. Qinna
Faculty of Pharmacy and Medical Sciences, University of Petra, Amman 11196, Jordan
7 shared publications - Ahmed Saad Abdulbari Ali Agha
Department of Pharmacy, Pharmacological and Diagnostic Research Centre, Al-Ahliyya Amman University, Amman 19111, Jordan
5 shared publications - Talal Aburjai
Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan
5 shared publications - Muhammed Alzweiri
Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan
4 shared publications - Thaqif El Khassawna
Experimental Trauma Surgery, Faculty of Medicine, Justus-Liebig-University of Giessen, Giessen, Germany
4 shared publications - Sara Khaleel
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan
2 shared publications
Latest Publications
- Open Access
- 13 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (8) , 1823
Alzheimer’s Disease as a Multi-Layer Network Disorder: A Systems Biology Framework Integrating Multi-Omics Mechanisms
Despite substantial progress in biomarker discovery and multi-omics profiling, several features of Alzheimer’s disease (AD), including prolonged compensated states, heterogeneous clinical trajectories, and marked stage-dependent therapeutic responses, remain difficult to integrate into a single mechanistic framework. In this review, we propose an integrative and testable conceptual framework that reframes AD as a single, progressive multi-layer network disorder whose dynamics arise from hierarchical constraint propagation and progressive loss of cross-scale coordination. Integrating evidence from human genetics, epigenomics, transcriptomics, proteomics, metabolomics, spatial biology, connectomics, and longitudinal biomarker studies, we examine how molecular, cellular, and circuit-level processes interact over time to shape disease progression. Within this framework, different omics measurements are interpreted as complementary representations of disease-related changes, rather than as independent molecular signatures. Disease progression reflects the gradual convergence of immune, metabolic, proteostatic, cytoskeletal, and synaptic stress, with overt cognitive impairment emerging when compensatory capacity is exceeded, producing threshold-like network destabilization. By explicitly linking biological scale, temporal hierarchy, and network structure, this synthesis extends prior network-medicine, connectomic, and multi-omics approaches into a testable framework for state-aware stratification, integrative analysis, and stage-appropriate therapeutic investigation in AD.
- 13 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (8) , 1823
Open AccessAlzheimer’s Disease as a Multi-Layer Network Disorder: A Systems Biology Framework Integrating Multi-Omics Mechanisms
Despite substantial progress in biomarker discovery and multi-omics profiling, several features of Alzheimer’s disease (AD), including prolonged compensated states, heterogeneous clinical trajectories, and marked stage-dependent therapeutic responses, remain difficult to integrate into a single mechanistic framework. In this review, we propose an integrative and testable conceptual framework that reframes AD as a single, progressive multi-layer network disorder whose dynamics arise from hierarchical constraint propagation and progressive loss of cross-scale coordination. Integrating evidence from human genetics, epigenomics, transcriptomics, proteomics, metabolomics, spatial biology, connectomics, and longitudinal biomarker studies, we examine how molecular, cellular, and circuit-level processes interact over time to shape disease progression. Within this framework, different omics measurements are interpreted as complementary representations of disease-related changes, rather than as independent molecular signatures. Disease progression reflects the gradual convergence of immune, metabolic, proteostatic, cytoskeletal, and synaptic stress, with overt cognitive impairment emerging when compensatory capacity is exceeded, producing threshold-like network destabilization. By explicitly linking biological scale, temporal hierarchy, and network structure, this synthesis extends prior network-medicine, connectomic, and multi-omics approaches into a testable framework for state-aware stratification, integrative analysis, and stage-appropriate therapeutic investigation in AD.
- Open Access
Alterations in the Multivariate Organization of Plasma Fatty Acid Profiles and Spontaneous Behavior in an AlCl3-Induced Rat Model of Neurotoxicity
Current experimental neurotoxicity research commonly relies on evaluating individual behavioral and biochemical endpoints, often without considering whether spontaneous behavior and lipid metabolism exhibit coordinated multivariate organization under toxicological stress. To address this question, the present study employed an integrative framework combining spontaneous behavioral profiling, targeted plasma fatty acid methyl ester (FAME) profiling, chemometric analyses, targeted assessment of cholinergic function, and permutation-based statistical validation in an AlCl3-induced rat model of neurotoxicity. Behavioral assessment was performed using the Y-maze, and multivariate organization was evaluated using covariance analyses, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), one-dimensional projection modeling, and nonparametric permutation testing (10,000 permutations). AlCl3 exposure was associated with early dose-related behavioral impairment at day 21 (ANOVA, p = 0.0006). In addition, both the measured fatty acid profiles and behavioral measures exhibited significant non-random multivariate organization, with progressive dose-related changes observed following AlCl3 exposure. Collectively, these findings suggest that neurotoxic exposure is associated with coordinated changes in the multivariate organization of measured fatty acid profiles, behavioral measures, and cholinergic function rather than isolated alterations in individual variables. Although confirmation in larger independent cohorts and broader molecular profiling remains warranted, the present findings support the use of multivariate organizational analysis as a complementary systems-level framework for investigating experimental neurotoxicity.
Open AccessAlterations in the Multivariate Organization of Plasma Fatty Acid Profiles and Spontaneous Behavior in an AlCl3-Induced Rat Model of Neurotoxicity
Current experimental neurotoxicity research commonly relies on evaluating individual behavioral and biochemical endpoints, often without considering whether spontaneous behavior and lipid metabolism exhibit coordinated multivariate organization under toxicological stress. To address this question, the present study employed an integrative framework combining spontaneous behavioral profiling, targeted plasma fatty acid methyl ester (FAME) profiling, chemometric analyses, targeted assessment of cholinergic function, and permutation-based statistical validation in an AlCl3-induced rat model of neurotoxicity. Behavioral assessment was performed using the Y-maze, and multivariate organization was evaluated using covariance analyses, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), one-dimensional projection modeling, and nonparametric permutation testing (10,000 permutations). AlCl3 exposure was associated with early dose-related behavioral impairment at day 21 (ANOVA, p = 0.0006). In addition, both the measured fatty acid profiles and behavioral measures exhibited significant non-random multivariate organization, with progressive dose-related changes observed following AlCl3 exposure. Collectively, these findings suggest that neurotoxic exposure is associated with coordinated changes in the multivariate organization of measured fatty acid profiles, behavioral measures, and cholinergic function rather than isolated alterations in individual variables. Although confirmation in larger independent cohorts and broader molecular profiling remains warranted, the present findings support the use of multivariate organizational analysis as a complementary systems-level framework for investigating experimental neurotoxicity.
- 8 July 2026
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 34 (5) , 354-360
Comparative Evaluation of APAFIX and 10% Formalin for Human Histologic Tissue Preservation: A Pilot Study
Formalin has long served as the standard fixative in histopathology; however, its limitations—such as antigen masking, nucleic acid degradation, and carcinogenicity—have prompted the search for safer alternatives. APAFIX, a formalin-free fixative, was developed to maintain diagnostic integrity while improving safety in routine tissue handling. This pilot study was conducted to compare the efficiency of the APAFIX solution with formalin in preserving human histologic tissue architecture and cellular morphology as assessed by routine Hematoxylin and Eosin (H and E) staining. Ten human biopsies from different tissue origins underwent standard H and E staining using the routine paraffin technique after 6 to 8 hours of postfixation in either APAFIX or 10% formalin. A blinded pathology review evaluated key histologic parameters, nuclear detail, lymphocyte visualization, fibrous tissue integrity, and overall tissue architecture, using a 10-point scoring system. Results revealed that APAFIX fixing solution was as effective as formalin fixation in terms of tissue quality during processing and sectioning, and in preserving architectural and cellular morphology. APAFIX solution showed enhanced nuclear detail and lymphocyte visualization with occasional fixation artifacts, such as pseudolipomatosis, observed in epithelial tissue. Formalin was more effective in preserving fibrous and epithelial areas. Overall, APAFIX demonstrated sufficient diagnostic performance across the studied pathologic biopsies. APAFIX is a promising formalin-free alternative for histologic tissue fixation, offering enhanced preservation of critical cellular features and eliminating health hazards associated with formalin. Further large-scale studies are warranted to validate its application across broader diagnostic settings and specialized staining techniques.
- 8 July 2026
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 34 (5) , 354-360
Comparative Evaluation of APAFIX and 10% Formalin for Human Histologic Tissue Preservation: A Pilot Study
Formalin has long served as the standard fixative in histopathology; however, its limitations—such as antigen masking, nucleic acid degradation, and carcinogenicity—have prompted the search for safer alternatives. APAFIX, a formalin-free fixative, was developed to maintain diagnostic integrity while improving safety in routine tissue handling. This pilot study was conducted to compare the efficiency of the APAFIX solution with formalin in preserving human histologic tissue architecture and cellular morphology as assessed by routine Hematoxylin and Eosin (H and E) staining. Ten human biopsies from different tissue origins underwent standard H and E staining using the routine paraffin technique after 6 to 8 hours of postfixation in either APAFIX or 10% formalin. A blinded pathology review evaluated key histologic parameters, nuclear detail, lymphocyte visualization, fibrous tissue integrity, and overall tissue architecture, using a 10-point scoring system. Results revealed that APAFIX fixing solution was as effective as formalin fixation in terms of tissue quality during processing and sectioning, and in preserving architectural and cellular morphology. APAFIX solution showed enhanced nuclear detail and lymphocyte visualization with occasional fixation artifacts, such as pseudolipomatosis, observed in epithelial tissue. Formalin was more effective in preserving fibrous and epithelial areas. Overall, APAFIX demonstrated sufficient diagnostic performance across the studied pathologic biopsies. APAFIX is a promising formalin-free alternative for histologic tissue fixation, offering enhanced preservation of critical cellular features and eliminating health hazards associated with formalin. Further large-scale studies are warranted to validate its application across broader diagnostic settings and specialized staining techniques.
- Open Access
Toward a Molecular Framework of Systemic Multi-Organ Toxicity Induced by Chronic Aluminum Chloride Exposure
Aluminum chloride (AlCl3) is widely used in experimental toxicology, particularly in rodent models of neurodegeneration, where its effects have been studied primarily in the central nervous system. However, experimental findings also indicate that chronic exposure is associated with changes across multiple peripheral organs, although these observations are often considered separately. In this review, we bring together evidence from different organ systems to examine aluminum toxicity from a broader perspective. Rather than focusing on isolated tissue-specific effects, we consider the extent to which reported findings may reflect overlapping molecular disturbances expressed across physiological systems. Within this context, organ-level outcomes are discussed as potentially related manifestations of shared underlying processes, while acknowledging variability in experimental conditions and model interpretation. To structure this synthesis, we outline a conceptual framework that links recurring molecular responses, system-level regulatory influences, and tissue-specific patterns of injury. This approach is intended to provide a more integrated way of organizing existing data rather than to establish a single unifying mechanism. Importantly, the pathological alterations discussed throughout this review are interpreted as experimentally observed toxicological manifestations of chronic AlCl3 exposure rather than evidence that aluminum constitutes a definitive etiological cause of Alzheimer’s disease. Overall, this review aims to complement existing neuro-focused interpretations of the AlCl3 model by situating it within a multi-organ context and highlighting areas where further integrative investigation may be warranted.
Open AccessToward a Molecular Framework of Systemic Multi-Organ Toxicity Induced by Chronic Aluminum Chloride Exposure
Aluminum chloride (AlCl3) is widely used in experimental toxicology, particularly in rodent models of neurodegeneration, where its effects have been studied primarily in the central nervous system. However, experimental findings also indicate that chronic exposure is associated with changes across multiple peripheral organs, although these observations are often considered separately. In this review, we bring together evidence from different organ systems to examine aluminum toxicity from a broader perspective. Rather than focusing on isolated tissue-specific effects, we consider the extent to which reported findings may reflect overlapping molecular disturbances expressed across physiological systems. Within this context, organ-level outcomes are discussed as potentially related manifestations of shared underlying processes, while acknowledging variability in experimental conditions and model interpretation. To structure this synthesis, we outline a conceptual framework that links recurring molecular responses, system-level regulatory influences, and tissue-specific patterns of injury. This approach is intended to provide a more integrated way of organizing existing data rather than to establish a single unifying mechanism. Importantly, the pathological alterations discussed throughout this review are interpreted as experimentally observed toxicological manifestations of chronic AlCl3 exposure rather than evidence that aluminum constitutes a definitive etiological cause of Alzheimer’s disease. Overall, this review aims to complement existing neuro-focused interpretations of the AlCl3 model by situating it within a multi-organ context and highlighting areas where further integrative investigation may be warranted.
- Open Access
State-Level Organization of Spontaneous Behavior and Its Association with Plasma Fatty-Acid Profiles in Healthy Rats
Individual variability in spontaneous behavior emerges from coordinated physiological states, yet the organization of baseline behavioral dimensions and their systemic metabolic correlations remains insufficiently characterized in healthy animals. Here, exploratory activity and self-directed grooming were quantified during a standardized Y-maze session and integrated with plasma fatty-acid profiles measured by orthogonal dual-column GC-MS in 30 healthy male Sprague–Dawley rats distributed across four independent cohorts. Correlation structure and principal component analysis showed that plasma lipid profiles exhibit non-random, low-dimensional organization, resolving into coherent compositional states dominated by coordinated shifts between shorter-chain (C14–C16) and longer-chain (C18) fatty-acid species. Behavioral variables are similarly organized into constrained dimensions capturing exploratory engagement and grooming expression or timing. Integrated correlation analysis indicated that plasma fatty-acid-derived lipid states aligned systematically with behavioral organization at the multivariate level across cohorts, with C18-enriched profiles generally aligned with higher behavioral engagement and earlier grooming expression at the state level, while C14/C16-enriched profiles associated with reduced exploration and delayed grooming initiation, although the direction of individual lipid–behavior correlations showed cohort dependence consistent with the context-dependent behavior of compositional lipid variables within distinct but physiologically normal lipidomic states. These findings demonstrate that state-level, correlation-based multivariate analysis can reveal structured plasma lipidomic configurations and their correspondence to behavioral organization under physiological conditions, without inferring causal directionality or pathway activation.
Open AccessState-Level Organization of Spontaneous Behavior and Its Association with Plasma Fatty-Acid Profiles in Healthy Rats
Individual variability in spontaneous behavior emerges from coordinated physiological states, yet the organization of baseline behavioral dimensions and their systemic metabolic correlations remains insufficiently characterized in healthy animals. Here, exploratory activity and self-directed grooming were quantified during a standardized Y-maze session and integrated with plasma fatty-acid profiles measured by orthogonal dual-column GC-MS in 30 healthy male Sprague–Dawley rats distributed across four independent cohorts. Correlation structure and principal component analysis showed that plasma lipid profiles exhibit non-random, low-dimensional organization, resolving into coherent compositional states dominated by coordinated shifts between shorter-chain (C14–C16) and longer-chain (C18) fatty-acid species. Behavioral variables are similarly organized into constrained dimensions capturing exploratory engagement and grooming expression or timing. Integrated correlation analysis indicated that plasma fatty-acid-derived lipid states aligned systematically with behavioral organization at the multivariate level across cohorts, with C18-enriched profiles generally aligned with higher behavioral engagement and earlier grooming expression at the state level, while C14/C16-enriched profiles associated with reduced exploration and delayed grooming initiation, although the direction of individual lipid–behavior correlations showed cohort dependence consistent with the context-dependent behavior of compositional lipid variables within distinct but physiologically normal lipidomic states. These findings demonstrate that state-level, correlation-based multivariate analysis can reveal structured plasma lipidomic configurations and their correspondence to behavioral organization under physiological conditions, without inferring causal directionality or pathway activation.
- Open Access
- 30 December 2025
- Published by MDPI AG in Applied Nano
- Vol. 7 (1) , 1
Comparative Characterization and Evaluation of WS6 Loaded Nanoformulations Using Solid Lipid, PLGA, and PCL Versus Eudragit RS/RL Prepared by Microfluidics
Objectives: This study aimed to optimize WS6-loaded nanoparticles (NPs) with favorable therapeutic properties, including appropriate size, low toxicity, high encapsulation efficiency, and enhanced biocompatibility, for selective cancer targeting and regenerative applications. Methods: Three formulations were investigated: solid lipid nanoparticles (SLNs), polycaprolactone (PCL)-based NPs, and Eudragit RS100-based NPs via microfluidic synthesis. Their physicochemical properties were assessed, followed by biological evaluation on normal cells—dental-derived stem cells (DSCs), gingival fibroblasts (GFs), and human dermal fibroblasts (HDFs)—and cancer cell lines MDA-231 and HepG2. Assays included MTT for viability, apoptosis/necrosis, cell cycle analysis, ROS detection, and cytokine profiling. Results: SLNs showed inherent toxicity despite improved viability upon WS6 loading. PCL NPs improved encapsulation and compatibility but lacked stability. The microfluidic RS-WS6 NPs exhibited optimal characteristics, significantly enhancing viability in normal cells and selectively inducing apoptosis in cancer cells. At 1 µM, RS-WS6 NPs reduced ROS in normal cells (p < 0.05) and increased it in cancer cells (p < 0.05). Cytokine analysis revealed significant downregulation of IL-6, IL-12p70, and TNF-α (p < 0.05), indicating immunomodulatory potential. Conclusions: RS-WS6 NPs developed via microfluidics offer a promising therapeutic platform with selective cytotoxicity against cancer cells, minimal toxicity to normal cells, and anti-inflammatory properties, supporting their use in targeted therapy and regenerative medicine.
- 30 December 2025
- Published by MDPI AG in Applied Nano
- Vol. 7 (1) , 1
Open AccessComparative Characterization and Evaluation of WS6 Loaded Nanoformulations Using Solid Lipid, PLGA, and PCL Versus Eudragit RS/RL Prepared by Microfluidics
Objectives: This study aimed to optimize WS6-loaded nanoparticles (NPs) with favorable therapeutic properties, including appropriate size, low toxicity, high encapsulation efficiency, and enhanced biocompatibility, for selective cancer targeting and regenerative applications. Methods: Three formulations were investigated: solid lipid nanoparticles (SLNs), polycaprolactone (PCL)-based NPs, and Eudragit RS100-based NPs via microfluidic synthesis. Their physicochemical properties were assessed, followed by biological evaluation on normal cells—dental-derived stem cells (DSCs), gingival fibroblasts (GFs), and human dermal fibroblasts (HDFs)—and cancer cell lines MDA-231 and HepG2. Assays included MTT for viability, apoptosis/necrosis, cell cycle analysis, ROS detection, and cytokine profiling. Results: SLNs showed inherent toxicity despite improved viability upon WS6 loading. PCL NPs improved encapsulation and compatibility but lacked stability. The microfluidic RS-WS6 NPs exhibited optimal characteristics, significantly enhancing viability in normal cells and selectively inducing apoptosis in cancer cells. At 1 µM, RS-WS6 NPs reduced ROS in normal cells (p < 0.05) and increased it in cancer cells (p < 0.05). Cytokine analysis revealed significant downregulation of IL-6, IL-12p70, and TNF-α (p < 0.05), indicating immunomodulatory potential. Conclusions: RS-WS6 NPs developed via microfluidics offer a promising therapeutic platform with selective cytotoxicity against cancer cells, minimal toxicity to normal cells, and anti-inflammatory properties, supporting their use in targeted therapy and regenerative medicine.